|
|
||||||||
Eur J Cardiothorac Surg 1998;14:S100-S104
© 1998 Elsevier Science NL
a Department of Cardiovascular/Thoracic Surgery, St. Vincent Hospital and Health Care Center Indianapolis, IN, USA
b Department of Cardiovascular/Thoracic Surgery, University of Louisville, Louisville, KY, USA
* Corresponding author. 8333 Naab Road, Suite 300, Indianapolis, IN 46260. Tel.: +1 317 3383551; fax: +1 317 3389209.
Objective: To evaluate the efficacy of transmyocardial revascularization performed on patients with refractory class IV or unstable angina with a holmium:yttrium-aluminum-garnet laser. Methods: Transmyocardial revascularization with a holmium:yttrium-aluminum-garnet laser was performed in 42 patients with refractory angina who were not candidates for percutaneous transluminal coronary angioplasty or coronary artery bypass grafting. Patients had either Canadian Heart Association class IV angina (n=23) or unstable angina (n=19) and were unable to be weaned from intravenous nitroglycerin. Preoperative thallium studies identified the extent and location of reversible ischemia. Operative exposure was via a limited left anterior thoracotomy. An average of 45±11 laser channels were created with a mean operative time of 106±38 min. Results: Perioperative mortality was 12% (5/42) with no late deaths. Complications included ventricular 7.1%(3/42) and atrial 4.7% (2/42) arrhythmias, reoperation for chest-wall hemorrhage 2% (1/42), and respiratory failure requiring reintubation 2% (1/42). Intra-aortic balloon pump placement was required in 12% (5/42). The mean postoperative length of stay was 5.5±4.9 (125) days. Mean follow-up on 100% of patients is 5.4±3.0 (112) months. At 3 (n=33) and 6 (n=21) months follow-up the mean angina class was 1.5±0.1 (P<0.002) and 1.1±0.1 (P<0.001), respectively. Conclusions: Transmyocardial revascularization utilizing a holmium:yttrium-aluminum-garnet laser resulted in a significant reduction in angina class and was beneficial in patients with refractory angina untreatable by conventional methods.
Key Words: Transmyocardial revascularization Holmium:YAG Laser Laser surgery
This article has been cited by other articles:
![]() |
J. Tasse and R. Arora Transmyocardial Revascularization: Peril and Potential Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2007; 12(1): 44 - 53. [Abstract] [PDF] |
||||
![]() |
K. B. Allen, R. D. Dowling, W. W. Angell, D. M. Gangahar, T. L. Fudge, W. Richenbacher, S. L. Selinger, M. R. Petracek, and D. Murphy Transmyocardial revascularization: 5-year follow-up of a prospective, randomized multicenter trial Ann. Thorac. Surg., April 1, 2004; 77(4): 1228 - 1234. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Loubani, D. Chin, J. N. Leverment, and M. Galinanes Mid-term results of combined transmyocardial laser revascularization and coronary artery bypass Ann. Thorac. Surg., October 1, 2003; 76(4): 1163 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. De Carlo, A. D. Milano, S. Pratali, M. Levantino, R. Mariotti, and U. Bortolotti Symptomatic improvement after transmyocardial laser revascularization: how long does it last? Ann. Thorac. Surg., September 1, 2000; 70(3): 1130 - 1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Allen, R. D. Dowling, T. L. Fudge, G. P. Schoettle, S. L. Selinger, D. M. Gangahar, W. W. Angell, M. R. Petracek, C. J. Shaar, and W. W. O'Neill Comparison of Transmyocardial Revascularization with Medical Therapy in Patients with Refractory Angina N. Engl. J. Med., September 30, 1999; 341(14): 1029 - 1036. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |